Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | EVP and General Counsel | December 21, 2022 | January 05, 2023 |
| CVS HEALTH CorpCVS · Entity 2884 | EVP, CPO and General Counsel | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date December 21, 2022 · Filed January 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,251 |
Reported balance
After 2022-12-21 transaction · row 1
1 source rowRow 1 · 2022-12-21 · Gift · Disposed 19 · Balance 9,251 |
CVS HEALTH Corp
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 38,139 |
Reported balance
After 2026-03-31 transaction · row 1
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 12,531 · Balance 38,139 F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| Common StockSEC Table I · non-derivative | Direct | 33,421 |
Reported balance
After 2026-04-01 transaction · row 2
1 source rowRow 2 · 2026-04-01 · Tax withholding · Disposed 3,541 · Balance 33,421 F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $71.82 · Expires 2036-03-31 | Direct | 80,838 |
Reported balance
After 2026-03-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-31 · Grant · Acquired 80,838 · Balance 80,838 F3: Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
F3: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,387.783 |
Reported balance
After 2017-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-14 · Gift · Disposed 48 · Balance 16,387.783 |
| Common StockSEC Table I · non-derivative | Direct | 25,016.783 |
Reported balance
After 2017-12-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-12-29 · Grant · Acquired 8,629 · Balance 25,016.783 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2: Includes 8,629 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Direct | 28,812.783 |
Reported balance
After 2017-12-29 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2017-12-29 · Grant · Acquired 3,796 · Balance 28,812.783 F3: Includes 3,796 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger. |
| Common StockSEC Table I · non-derivative | Direct | 28,587 |
Reported balance
After 2017-12-29 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2017-12-29 · Disposition to issuer · Disposed 225.783 · Balance 28,587 F4: Includes 225.7830 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. |
| Common StockSEC Table I · non-derivative | Direct | 20,008 |
Reported balance
After 2017-12-29 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2017-12-29 · Disposition to issuer · Disposed 8,579 · Balance 20,008 F5: Includes 8,579 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 11,379 |
Reported balance
After 2017-12-29 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2017-12-29 · Disposition to issuer · Disposed 8,629 · Balance 11,379 F2: Includes 8,629 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2017-12-29 · Disposition to issuer · Disposed 11,379 · Balance 0 F6: Includes 11,379 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $145.83 · Expires 2024-07-16 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-12-29 · Disposition to issuer · Disposed 9,184 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $186.43 · Expires 2025-12-09 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-12-29 · Disposition to issuer · Disposed 9,659 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.87 · Expires 2024-12-10 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-12-29 · Disposition to issuer · Disposed 8,006 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $219.56 · Expires 2026-12-14 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-12-29 · Disposition to issuer · Disposed 8,149 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger.
F2: Includes 8,629 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
F3: Includes 3,796 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.
F4: Includes 225.7830 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
F5: Includes 8,579 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.
F6: Includes 11,379 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.
F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,541 | $72.49 | $256,687.09 |
DisclosureSEC source: 0000064803-26-000039 · form4.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,421 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 80,838 | $71.82 Strike: $71.82 | $5,805,785.16 |
DisclosureSEC source: 0000064803-26-000039 · form4.xml · derivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,838 Underlying: Common Stock · 80,838 shares Expires 2036-03-31 F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,531 | $71.82 | $899,976.42 |
DisclosureSEC source: 0000064803-26-000039 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,139 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 22:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 7,886 | $79.60 | $627,725.60 |
DisclosureSEC source: 0000064803-26-000015 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,775 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 68,621 | $67.98 Strike: $67.98 | $4,664,855.58 |
DisclosureSEC source: 0001127602-25-011410 · form4.xml · derivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,621 Underlying: Common Stock · 68,621 shares Expires 2035-04-01 F3 · security: Option becomes exercisable in four equal annual installments, commencing on 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 16,181 | $67.98 | $1,099,984.38 |
DisclosureSEC source: 0001127602-25-011410 · form4.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,569 F2 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,548 | $67.98 | $105,233.04 |
DisclosureSEC source: 0001127602-25-011410 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,700 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 5,604 | $65.72 | $368,294.88 |
DisclosureSEC source: 0001127602-25-007558 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,106 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 52,246 | $79.56 Strike: $79.56 | $4,156,691.76 |
DisclosureSEC source: 0001127602-24-012261 · form4.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,246 Underlying: Common Stock · 52,246 shares Expires 2034-04-01 F2 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012261 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,490 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,210 | $75.19 | $466,929.90 |
DisclosureSEC source: 0001127602-24-007927 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,750 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 66,805 | $74.31 Strike: $74.31 | $4,964,279.55 |
DisclosureSEC source: 0001127602-23-012237 · form4.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,805 Underlying: Common Stock · 66,805 shares Expires 2033-04-01 F1 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 47,881 | $83.54 | $3,999,978.74 |
DisclosureSEC source: 0001127602-23-007957 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP, CPO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,881 F1 · kind: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 2/28/2024. Read SEC document |
| December 21, 2022 Filed Jan 5, 2023 20:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000486 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,251 Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023886 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,270 Read SEC document |
| November 26, 2022 Filed Nov 30, 2022 00:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 12,484 | $0.00 Strike: $238.06 | $0.00 |
DisclosureSEC source: 0001062993-22-022954 · form4.xml · derivative · entry 4 Khichi Samrat S. · CIK 0001612227 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,484 Underlying: Common Stock · 12,484 shares Expires 2032-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023. Read SEC document |
| November 26, 2022 Filed Nov 30, 2022 00:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022954 · form4.xml · nonDerivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,310 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2022 Filed Nov 30, 2022 00:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022954 · form4.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,218 F2 · shares: Represents shares received upon vesting of performance based equity awards. Read SEC document |
| November 26, 2022 Filed Nov 30, 2022 00:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022954 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,262 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 12,489 | $0.00 Strike: $108.25 | $0.00 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · derivative · entry 8 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,489 shares Expires 2024-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning one year from grant. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 14,326 | $0.00 Strike: $93.49 | $0.00 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · derivative · entry 7 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,326 shares Expires 2024-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. F3 · shares: Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning one year from grant. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 5,194 | $260.44 | $1,352,725.36 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 5 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,223 Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 12,489 | $108.25 | $1,351,934.25 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 4 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 9,185 | $260.44 | $2,392,141.40 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual prices for the transactions ranged from $260.00 through $261.71. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 11, 2022. F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 5,141 | $260.44 | $1,338,922.04 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,113 Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 14,326 | $93.49 | $1,339,337.74 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2022 Filed Aug 11, 2022 20:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 7,295 | $260.44 | $1,899,909.80 |
DisclosureSEC source: 0001062993-22-017739 · form4.xml · nonDerivative · entry 6 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual prices for the transactions ranged from $260.00 through $261.71. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 11, 2022. F2 · balance_after: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 15:18 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003421 · form4.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 13,678 | $0.00 Strike: $245.09 | $0.00 |
DisclosureSEC source: 0001543407-21-000056 · edgar.xml · derivative · entry 4 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,678 Underlying: Common Stock · 13,678 shares Expires 2031-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2022. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000056 · edgar.xml · nonDerivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,303 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000056 · edgar.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,389 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 990 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000056 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,070 F1 · shares: Represents shares vesting under performance units granted on November 26, 2018. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 20:01 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 1,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000020 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,080 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 13:35 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000003 · edgar.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 13:35 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000003 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,365 F1 · shares: Represents shares vesting under performance units granted on January 2, 2018. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 22:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 5,001 | $0.00 Strike: $227.47 | $0.00 |
DisclosureSEC source: 0001543407-20-000055 · edgar.xml · derivative · entry 3 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,001 Underlying: Common Stock · 5,001 shares Expires 2030-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in three annual installments beginning November 26, 2021. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 22:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 14,984 | $0.00 Strike: $227.47 | $0.00 |
DisclosureSEC source: 0001543407-20-000055 · edgar.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,984 Underlying: Common Stock · 14,984 shares Expires 2030-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2021. Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 22:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 192 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000055 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,070 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 17:03 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 4,349 | $224.53 | $976,480.97 |
DisclosureSEC source: 0001543407-20-000030 · edgar.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,262 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $211.05 through $232.75. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on March 2, 2020. Read SEC document |
| February 19, 2020 Filed Mar 17, 2020 17:03 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000030 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,611 Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:10 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 2,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000027 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,806 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:01 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000003 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,144 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:33 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 12,627 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000065 · edgar.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 Underlying: Common Stock · 12,627 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:33 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 192 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000065 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| September 05, 2019 Filed Sep 30, 2019 17:23 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 59 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000051 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,549 Read SEC document |
| May 21, 2019 Filed May 23, 2019 16:30 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 16,085 | $234.68 | $3,774,827.80 |
DisclosureSEC source: 0001543407-19-000031 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,608 F1 · shares: Includes shares acquired through dividend reinvestment since the last report filed by the reporting person. F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $233.94 through $235.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 14:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 3,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000019 · edgar.xml · nonDerivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,681 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| January 04, 2019 Filed Feb 13, 2019 14:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GiftCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000019 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,220 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 15:16 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 216 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000004 · edgar.xml · nonDerivative · entry 1 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,289 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 14:04 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 10,628 | $0.00 Strike: $242.10 | $0.00 |
DisclosureSEC source: 0001543407-18-000077 · edgar.xml · derivative · entry 2 Khichi Samrat S. · CIK 0001612227 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,628 Underlying: Common Stock · 10,628 shares Expires 2028-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.